The endoplasmic reticulum (ER): a crucial cellular hub in flavivirus infection and potential target site for antiviral interventions

[1]  Sidhant Jain,et al.  Dengue Vaccination: Towards a New Dawn of Curbing Dengue Infection , 2023, Immunological investigations.

[2]  A. Faisal,et al.  Repurposing of investigational cancer drugs: Early phase discovery of dengue virus NS2B/NS3 protease inhibitors , 2023, Archiv der Pharmazie.

[3]  D. Sahoo,et al.  Role of endoplasmic reticulum stress-related unfolded protein response and its implications in dengue virus infection for biomarker development. , 2023, Life sciences.

[4]  R. Jia,et al.  Secretory pathways and multiple functions of nonstructural protein 1 in flavivirus infection , 2023, Frontiers in immunology.

[5]  R. D. del Ángel,et al.  Cholesterol-Lowering Drugs as Potential Antivirals: A Repurposing Approach against Flavivirus Infections , 2023, Viruses.

[6]  J. Chu,et al.  Antiviral Activity of Catechin against Dengue Virus Infection , 2023, Viruses.

[7]  A. S. St. John,et al.  Dengue: Update on Clinically Relevant Therapeutic Strategies and Vaccines , 2023, Current Treatment Options in Infectious Diseases.

[8]  Gregory D. Gromowski,et al.  Blocking NS3–NS4B interaction inhibits dengue virus in non-human primates , 2023, Nature.

[9]  Bing Liang Alvin Chew,et al.  Flavivirus nonstructural proteins and replication complexes as antiviral drug targets. , 2023, Current opinion in virology.

[10]  C. Poh,et al.  Molecular Mechanisms of Antiviral Agents against Dengue Virus , 2023, Viruses.

[11]  Priscila Sutto-Ortiz,et al.  AT-752 targets multiple sites and activities on the Dengue virus replication enzyme NS5. , 2023, Antiviral research.

[12]  C. Klein,et al.  N-sulfonyl peptide-hybrids as a new class of dengue virus protease inhibitors. , 2023, European journal of medicinal chemistry.

[13]  M. Rahman,et al.  S-Adenosyl-l-Homocysteine Exhibits Potential Antiviral Activity Against Dengue Virus Serotype-3 (DENV-3) in Bangladesh: A Viroinformatics-Based Approach , 2023, Bioinformatics and biology insights.

[14]  Y. Ci,et al.  Bortezomib inhibits ZIKV/DENV by interfering with viral polyprotein cleavage via the ERAD pathway. , 2022, Cell chemical biology.

[15]  R. Hegde,et al.  The Biogenesis of Multipass Membrane Proteins. , 2022, Cold Spring Harbor perspectives in biology.

[16]  K. Spurgers,et al.  Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects , 2022, PLoS neglected tropical diseases.

[17]  Billy Tsai,et al.  A specific EMC subunit supports Dengue virus infection by promoting virus membrane fusion essential for cytosolic genome delivery , 2022, PLoS pathogens.

[18]  S. Chanda,et al.  Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity , 2022, ACS infectious diseases.

[19]  Priya S. Shah,et al.  Let’s Get Physical: Flavivirus-Host Protein–Protein Interactions in Replication and Pathogenesis , 2022, Frontiers in Microbiology.

[20]  M. N. Anwar,et al.  Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review , 2021, Viruses.

[21]  R. Mariuzza,et al.  N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity. , 2021, Journal of medicinal chemistry.

[22]  R. Schülein,et al.  Inhibitors of the Sec61 Complex and Novel High Throughput Screening Strategies to Target the Protein Translocation Pathway , 2021, International journal of molecular sciences.

[23]  S. Alonso,et al.  In vitro and in vivo efficacy of Metformin against dengue. , 2021, Antiviral research.

[24]  R. D. del Ángel,et al.  Anti-flavivirus Properties of Lipid-Lowering Drugs , 2021, Frontiers in Physiology.

[25]  Peggy Geluykens,et al.  A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction , 2021, Nature.

[26]  Vianney Tricou,et al.  Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003) , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Bartenschlager,et al.  The Biogenesis of Dengue Virus Replication Organelles Requires the ATPase Activity of Valosin-Containing Protein , 2021, Viruses.

[28]  Youichi Suzuki,et al.  Membrane-Associated Flavivirus Replication Complex—Its Organization and Regulation , 2021, Viruses.

[29]  Billy Tsai,et al.  How DNA and RNA Viruses Exploit Host Chaperones to Promote Infection , 2021, Viruses.

[30]  D. Luo,et al.  Molecular Insights into the Flavivirus Replication Complex , 2021, Viruses.

[31]  J. E. Muñoz-Medina,et al.  The antiviral effect of metformin on zika and dengue virus infection , 2021, Scientific Reports.

[32]  Y. Ci,et al.  Compartmentalized replication organelle of flavivirus at the ER and the factors involved , 2021, Cellular and Molecular Life Sciences.

[33]  G. Bonamy,et al.  NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models , 2021, Science Translational Medicine.

[34]  F. Förster,et al.  Structure of the Human Signal Peptidase Complex Reveals the Determinants for Signal Peptide Cleavage , 2020, bioRxiv.

[35]  S. Yoksan,et al.  Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus , 2020, Scientific Reports.

[36]  Xinwen Chen,et al.  Dengue NS2A Protein Orchestrates Virus Assembly. , 2019, Cell host & microbe.

[37]  J. Chu,et al.  Antiviral activity of ST081006 against the Dengue virus. , 2019, Antiviral research.

[38]  R. Hegde,et al.  The Role of EMC during Membrane Protein Biogenesis. , 2019, Trends in cell biology.

[39]  Billy Tsai,et al.  The ER Membrane Protein Complex Promotes Biogenesis of Dengue and Zika Virus Non-structural Multi-pass Transmembrane Proteins to Support Infection , 2019, Cell reports.

[40]  E. Harris,et al.  Flavivirus NS1 Triggers Tissue-Specific Vascular Endothelial Dysfunction Reflecting Disease Tropism , 2019, Cell reports.

[41]  D. James,et al.  Targeting host metabolism by inhibition of acetyl-Coenzyme A carboxylase reduces flavivirus infection in mouse models , 2019, Emerging microbes & infections.

[42]  Priya S. Shah,et al.  Comparative Flavivirus-Host Protein Interaction Mapping Reveals Mechanisms of Dengue and Zika Virus Pathogenesis , 2018, Cell.

[43]  Yi-Ling Lin,et al.  Novel AR-12 derivatives, P12-23 and P12-34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis , 2018, Emerging Microbes & Infections.

[44]  R. Hegde,et al.  EMC Is Required to Initiate Accurate Membrane Protein Topogenesis , 2018, Cell.

[45]  E. Sztul,et al.  Role of Host Cell Secretory Machinery in Zika Virus Life Cycle , 2018, Viruses.

[46]  R. D. del Ángel,et al.  Ezetimibe inhibits Dengue virus infection in Huh-7 cells by blocking the cholesterol transporter Niemann–Pick C1-like 1 receptor , 2018, bioRxiv.

[47]  M. Garcia-Blanco,et al.  Biochemistry and Molecular Biology of Flaviviruses. , 2018, Chemical reviews.

[48]  F. Förster,et al.  Structural basis for coupling protein transport and N-glycosylation at the mammalian endoplasmic reticulum , 2018, Science.

[49]  R. Bartenschlager,et al.  Rewiring cellular networks by members of the Flaviviridae family , 2018, Nature Reviews Microbiology.

[50]  P. Vidalain,et al.  A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors. , 2017, Cell reports.

[51]  R. Hegde,et al.  The ER membrane protein complex is a transmembrane domain insertase , 2017, Science.

[52]  J. Carette,et al.  A Small-Molecule Oligosaccharyltransferase Inhibitor with Pan-flaviviral Activity. , 2017, Cell reports.

[53]  C. Simmons,et al.  The Host Protein Reticulon 3.1A Is Utilized by Flaviviruses to Facilitate Membrane Remodelling. , 2017, Cell reports.

[54]  T. Rapoport,et al.  Structural and Mechanistic Insights into Protein Translocation. , 2017, Annual review of cell and developmental biology.

[55]  S. Tajima,et al.  Hirsutine, an Indole Alkaloid of Uncaria rhynchophylla, Inhibits Late Step in Dengue Virus Lifecycle , 2017, Front. Microbiol..

[56]  Yee‐Shin Lin,et al.  AR‐12 suppresses dengue virus replication by down‐regulation of PI3K/AKT and GRP78 , 2017, Antiviral research.

[57]  N. Vasilakis,et al.  Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond , 2017, Nature Reviews Drug Discovery.

[58]  G. Bonamy,et al.  The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase. , 2017, Cell reports.

[59]  R. D. del Ángel,et al.  DENV up-regulates the HMG-CoA reductase activity through the impairment of AMPK phosphorylation: A potential antiviral target , 2017, PLoS pathogens.

[60]  R. Bartenschlager,et al.  Peptide-Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology. , 2017, Journal of medicinal chemistry.

[61]  Jennifer E. Golden,et al.  Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells. , 2016, Nature chemical biology.

[62]  A. Balasubramanian,et al.  High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease. , 2016, Antiviral research.

[63]  J. Saiz,et al.  Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses. , 2016, Progress in lipid research.

[64]  A. Rivas-Estilla,et al.  The anti‑dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression. , 2016, Molecular medicine reports.

[65]  Hongping Dong,et al.  Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling , 2016, PLoS pathogens.

[66]  Uma S. Kamaraj,et al.  Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients , 2016, PLoS neglected tropical diseases.

[67]  S. Tajima,et al.  Novel antiviral activity of bromocriptine against dengue virus replication. , 2016, Antiviral research.

[68]  A. Brass,et al.  Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. , 2016, Cell reports.

[69]  Joshua E. Elias,et al.  Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens , 2016, Nature.

[70]  T. Pierson,et al.  A CRISPR screen defines a signal peptide processing pathway required by flaviviruses , 2016, Nature.

[71]  R. Dwek,et al.  Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4 , 2016, Antiviral research.

[72]  S. H. Muharram,et al.  Glycosylation of dengue virus glycoproteins and their interactions with carbohydrate receptors: possible targets for antiviral therapy , 2016, Archives of Virology.

[73]  Paul W Smith,et al.  Discovery of Potent Non-Nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from a Fragment Hit Using Structure-Based Drug Design. , 2016, Journal of medicinal chemistry.

[74]  Priscilla L. Yang,et al.  Lactimidomycin is a broad-spectrum inhibitor of dengue and other RNA viruses. , 2016, Antiviral research.

[75]  S. Vasudevan,et al.  Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy. , 2016, Antiviral research.

[76]  Leo Uchida,et al.  Suppressive Effects of the Site 1 Protease (S1P) Inhibitor, PF-429242, on Dengue Virus Propagation , 2016, Viruses.

[77]  Priya S. Shah,et al.  Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. , 2016, Immunity.

[78]  R. Bartenschlager,et al.  Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue. , 2015, Journal of medicinal chemistry.

[79]  Xuping Xie,et al.  Secondary structure and membrane topology of dengue virus NS4B N-terminal 125 amino acids. , 2015, Biochimica et biophysica acta.

[80]  R. Andino,et al.  Defining Hsp70 Subnetworks in Dengue Virus Replication Reveals Key Vulnerability in Flavivirus Infection , 2015, Cell.

[81]  E. Ooi,et al.  Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection , 2015, PLoS neglected tropical diseases.

[82]  R. Bartenschlager,et al.  Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors. , 2015, Journal of medicinal chemistry.

[83]  Xu Shen,et al.  Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells , 2015, Acta Pharmacologica Sinica.

[84]  K. Choi,et al.  Flaviviral Replication Complex: Coordination between RNA Synthesis and 5′-RNA Capping , 2015, Viruses.

[85]  Susan A. Jones,et al.  Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase. , 2015, ACS infectious diseases.

[86]  Ling Qi,et al.  A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death. , 2015, Cell reports.

[87]  R. Hall,et al.  Post-translational regulation and modifications of flavivirus structural proteins. , 2015, Journal of General Virology.

[88]  Hongmin Li,et al.  5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus. , 2015, Journal of medicinal chemistry.

[89]  A. Sampath,et al.  A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue) , 2015, Viruses.

[90]  C. García,et al.  Antiviral activity of an N-allyl acridone against dengue virus , 2015, Journal of Biomedical Science.

[91]  Gunnar von Heijne,et al.  Mechanisms of integral membrane protein insertion and folding. , 2015, Journal of molecular biology.

[92]  Alicia M. Hanson,et al.  Benzothiazole and Pyrrolone Flavivirus Inhibitors Targeting the Viral Helicase. , 2015, ACS infectious diseases.

[93]  Paul W Smith,et al.  Lead optimization of spiropyrazolopyridones: a new and potent class of dengue virus inhibitors. , 2015, ACS medicinal chemistry letters.

[94]  M. Castanho,et al.  Receptors and routes of dengue virus entry into the host cells. , 2015, FEMS microbiology reviews.

[95]  Subhash G. Vasudevan,et al.  Suramin inhibits helicase activity of NS3 protein of dengue virus in a fluorescence-based high throughput assay format. , 2014, Biochemical and biophysical research communications.

[96]  A. Siddiqui,et al.  Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of dengue virus. , 2014, Antiviral research.

[97]  M. Martínez-Gutiérrez,et al.  Lovastatin Delays Infection and Increases Survival Rates in AG129 Mice Infected with Dengue Virus Serotype 2 , 2014, PloS one.

[98]  T. Yasunaga,et al.  A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication. , 2013, Biochemical and biophysical research communications.

[99]  Ralf Bartenschlager,et al.  Thiazolidinone-peptide hybrids as dengue virus protease inhibitors with antiviral activity in cell culture. , 2013, Journal of medicinal chemistry.

[100]  J. Neyts,et al.  Identification of a new dengue virus inhibitor that targets the viral NS4B protein and restricts genomic RNA replication. , 2013, Antiviral research.

[101]  Mary Ann Comunale,et al.  Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses. , 2013, Antiviral research.

[102]  D. Gubler,et al.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis , 2013, Nature Reviews Microbiology.

[103]  John S. Brownstein,et al.  The global distribution and burden of dengue , 2013, Nature.

[104]  S. Halstead,et al.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection , 2013, Archives of Virology.

[105]  H. Rothan,et al.  Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1 , 2012, BMC Infectious Diseases.

[106]  B. M. Pinto,et al.  Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus. , 2012, International journal of antimicrobial agents.

[107]  Alicia M. Hanson,et al.  Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug. , 2012, The Journal of antimicrobial chemotherapy.

[108]  Niranjan Nagarajan,et al.  A Randomized, Double-Blind Placebo Controlled Trial of Balapiravir, a Polymerase Inhibitor, in Adult Dengue Patients , 2012, The Journal of infectious diseases.

[109]  Jinhong Chang,et al.  Design, synthesis, and biological evaluation of N-alkylated deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection. , 2012, Journal of medicinal chemistry.

[110]  Alicia M. Hanson,et al.  Identification and analysis of hepatitis C virus NS3 helicase inhibitors using nucleic acid binding assays , 2012, Nucleic acids research.

[111]  D. Finley,et al.  A small-molecule inhibitor of deubiquitinating enzyme USP14 inhibits Dengue virus replication. , 2012, Virus research.

[112]  J. Connolly,et al.  Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model. , 2011, Antiviral research.

[113]  W. Schul,et al.  Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection. , 2011, Antiviral research.

[114]  M. Garcia-Blanco,et al.  The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly , 2011, PloS one.

[115]  V. Simon,et al.  Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis , 2011, Proceedings of the National Academy of Sciences.

[116]  M. Martínez-Gutiérrez,et al.  Statins Reduce Dengue Virus Production via Decreased Virion Assembly , 2011, Intervirology.

[117]  M. Guzmán,et al.  The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection , 2010, Viruses.

[118]  N. Heaton,et al.  Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis , 2010, Proceedings of the National Academy of Sciences.

[119]  Shui-Tein Chen,et al.  The ubiquitin-proteasome pathway is important for dengue virus infection in primary human endothelial cells. , 2010, Journal of proteome research.

[120]  M. McDowell,et al.  A novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro. , 2010, Antiviral research.

[121]  P. Shi,et al.  Higher catalytic efficiency of N-7-methylation is responsible for processive N-7 and 2'-O methyltransferase activity in dengue virus. , 2010, Virology.

[122]  Zhiming Yuan,et al.  Identification of palmatine as an inhibitor of West Nile virus , 2010, Archives of Virology.

[123]  P. Niyomrattanakit,et al.  An adenosine nucleoside inhibitor of dengue virus , 2009, Proceedings of the National Academy of Sciences.

[124]  A. Gamarnik,et al.  Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation , 2009, PLoS pathogens.

[125]  M. Labow,et al.  Cholesterol biosynthesis modulation regulates dengue viral replication. , 2009, Virology.

[126]  Yuan-Ping Pang,et al.  Structure-based discovery of dengue virus protease inhibitors. , 2009, Antiviral research.

[127]  M. Garcia-Blanco,et al.  Discovery of Insect and Human Dengue Virus Host Factors , 2009, Nature.

[128]  Ralf Bartenschlager,et al.  Composition and Three-Dimensional Architecture of the Dengue Virus Replication and Assembly Sites , 2009, Cell Host & Microbe.

[129]  S. Collins,et al.  Comprehensive Characterization of Genes Required for Protein Folding in the Endoplasmic Reticulum , 2009, Science.

[130]  P. Yenchitsomanus,et al.  Interaction of dengue virus envelope protein with endoplasmic reticulum-resident chaperones facilitates dengue virus production. , 2009, Biochemical and biophysical research communications.

[131]  P. Shi,et al.  A single-amino acid substitution in West Nile virus 2K peptide between NS4A and NS4B confers resistance to lycorine, a flavivirus inhibitor , 2008, Virology.

[132]  Ruth R. Montgomery,et al.  RNA interference screen for human genes associated with West Nile virus infection , 2008, Nature.

[133]  Richard J Kuhn,et al.  Structural proteomics of dengue virus. , 2008, Current opinion in microbiology.

[134]  D. A. Stein,et al.  Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus , 2008, The Journal of antimicrobial chemotherapy.

[135]  M. Rossmann,et al.  The Flavivirus Precursor Membrane-Envelope Protein Complex: Structure and Maturation , 2008, Science.

[136]  T. Rapoport.  Protein translocation across the eukaryotic endoplasmic reticulum and bacterial plasma membranes , 2007, Nature.

[137]  Joshy George,et al.  Host Gene Expression Profiling of Dengue Virus Infection in Cell Lines and Patients , 2007, PLoS neglected tropical diseases.

[138]  J. Chu,et al.  c-Src protein kinase inhibitors block assembly and maturation of dengue virus , 2007, Proceedings of the National Academy of Sciences.

[139]  C. Cameron,et al.  Inhibition of dengue virus replication by mycophenolic acid and ribavirin. , 2006, The Journal of general virology.

[140]  Tan Siew Kiat,et al.  Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. , 2006, Bioorganic & medicinal chemistry letters.

[141]  D. A. Stein,et al.  Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3' stem-loop structure. , 2006, Virology.

[142]  Chi‐Huey Wong,et al.  Novel Five‐Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis , 2006, Chembiochem : a European journal of chemical biology.

[143]  T. Rapoport,et al.  Membrane-protein integration and the role of the translocation channel. , 2004, Trends in cell biology.

[144]  M. Diamond,et al.  Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. , 2002, Virology.

[145]  J. Neyts,et al.  A novel model for the study of the therapy of flavivirus infections using the Modoc virus. , 2001, Virology.

[146]  C. Lai,et al.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins , 1991, Journal of virology.

[147]  A. Ruiz-Linares,et al.  Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins , 1989, Journal of virology.

[148]  L. Markoff.  In vitro processing of dengue virus structural proteins: cleavage of the pre-membrane protein , 1989, Journal of virology.

[149]  R. Chanock,et al.  Proper processing of dengue virus nonstructural glycoprotein NS1 requires the N-terminal hydrophobic signal sequence and the downstream nonstructural protein NS2a , 1989, Journal of virology.

[150]  S. Halstead,et al.  Dengue infection , 2016, Nature Reviews Disease Primers.

[151]  Xuping Xie,et al.  U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. , 2012, Antiviral research.